» Articles » PMID: 10771434

Crystallization and Molecular-replacement Solution of a Truncated Form of Human Recombinant Tetranectin

Overview
Specialty Chemistry
Date 2000 Apr 20
PMID 10771434
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The two C-terminal domains, TN23 (residues 17-181), of human recombinant tetranectin, a plasminogen kringle 4 binding C-type lectin, have been crystallized in two different space groups. Using PEG 8000 as precipitant and at a pH of 8.5, crystals belonging to the monoclinic space group C2 are obtained, with unit-cell parameters a = 160.4, b = 44.7, c = 107.5 A, beta = 127.6 degrees. Using sodium formate as precipitant and at a pH of 5.0, TN23 crystallizes in a rhombohedral space group, with unit-cell parameters a = b = c = 107.4 A, alpha = beta = gamma = 78.3 degrees. A full data set to 4.5 A has been collected from the monoclinic crystals. Using the structure of full-length tetranectin, a molecular-replacement solution has been obtained. The crystal packing shows that TN23 crystallizes as a trimer, with one trimer in the asymmetric unit.

Citing Articles

Insight into the function of tetranectin in human diseases: A review and prospects for tetranectin-targeted disease treatment.

Iram S, Rahman S, Choi I, Kim J Heliyon. 2024; 10(1):e23512.

PMID: 38187250 PMC: 10770464. DOI: 10.1016/j.heliyon.2023.e23512.


Aberrant tetranectin expression in human breast carcinomas as a predictor of survival.

Obrist P, Spizzo G, Ensinger C, Fong D, Brunhuber T, Schafer G J Clin Pathol. 2004; 57(4):417-21.

PMID: 15047748 PMC: 1770261. DOI: 10.1136/jcp.2003.010058.